27Mar, 2019

Chronic Pelvic Pain in Men

By: | Tags: , , , , , , , , , , , , , , ,

-Definition As in the case of women, a significant percentage of men suffer during their lifetime from pelvic pain that is not precisely localised. When the pain is present for a period longer than 3 months, it is called chronic pelvic pain. It is located in the pelvis, perineum or genitals. There may also be pain in the suprapubic area, also in the penis or testicles. There may also be urinary signs such as dysuria (discomfort in urination) and pain when ejaculating, decreased jet and urinary urgency and even sexual […]

12Oct, 2018

Vigorexia the other epidemic

By: | Tags: , , , , , , , , , ,

-Introduction: Although it was described in 1993 by Pope in regular bodybuilders to go to the gym and the side effects of anabolic steroids in these people, in the manual DSM-IV, was included within the dysmorphobias, now in the DSM-V, is included as a body dysmorphic disorder, it is considered that muscular dysmorphia or vigorexia is a disorder in which the person is obsessed by their physical condition to pathological levels. These people have a distorted view of themselves and look weak and unattractive. For this reason, the disorder directly […]

15Sep, 2018

Insensitivity to mild androgens

By: | Tags: , , , , , , , , , , , , , ,

Definition: Mild androgen insensitivity syndrome is a condition that results in a mild impairment of the cell’s ability to respond to androgens. The degree of impairment is sufficient to jeopardize spermatogenesis and/or the development of secondary sexual characteristics at puberty in men, but does not affect genital differentiation or development, it is also known as: Mild androgen insensitivity syndrome (MAIS). The clinical phenotype associated with MAIS is a normal male type with mild spermatogenesis defects and/or secondary terminal hair reduction. It should not be confused with the complete androgen insensitivity […]

28Jul, 2018

Antiestrogens in the Clinic

By: | Tags: , , , , , , , , , , ,

They are called antiestrogens to a group of drugs that have the characteristic of inhibiting the action of estrogens. This action is achieved through the union of these substances to estrogen receptors blocking them. These are found in the cells of sensitive tissues. When they enter the receptor, they prevent estrogens from occupying it, thus preventing the action of them, another mechanism of action is through the inhibition of estrogen production by enzymatic blocking of aromatase. -Classes according to action mechanism: -Group 1: They are called selective estrogen receptor modulators […]